Skip to main content

Table 3 Logistic regression model comparing 12 end-of-life care outcomes for three age groups (in years) and for men and women, adjusted for place of death (hospital/nursing home). Odds ratios (OR) and 95% confidence intervals (CI) are reported

From: Better quality of end-of-life care for persons with advanced dementia in nursing homes compared to hospitals: a Swedish national register study

 

n

%

OR

95% CI

p

PRN drugs against pain

 Age

  41–64

88/95

92.6

1.006

0.464–2.185

0.987

  65–84

4799/5086

94.4

1.335

1.159–1.537

< 0.001

  85–110

10,413/11,219

92.8

Refa

 Gender

  Women

10,342/11,081

93.3

1.006

0.880–1.149

0.931

  Men

4958/5319

93.2

Refa

PRN drugs against nausea

 Age

  41–64

59/94

62.8

1.108

0.726–1.691

0.636

  65–84

3131/5037

62.2

1.069

0.997–1.147

0.060

  85–110

6814/11,106

61.4

Refa

 Gender

  Women

6832/10,984

62.2

1.038

0.969–1.113

0.285

  Men

3172/5253

60.4

Refa

PRN drugs against anxiety

 Age

  41–64

79/94

84.0

0.991

0.568–1.730

0.975

  65–84

4342/5063

85.8

1.127

1.024–1.240

0.014

  85–110

9455/11,172

84.6

Refa

 Gender

  Women

9405/11,041

85.2

1.017

0.926–1.116

0.728

  Men

4471/5288

84.5

Refa

Pain assessed and documented during the last week of life

 Age

  41–64

29/93

31.2

1.025

0.658–1.595

0.914

  65–84

1550/4916

31.5

1.039

0.965–1.118

0.313

  85–110

3399/10,834

31.4

Refa

 Gender

  Women

3428/10,726

32.0

1.042

0.968–1.121

0.277

  Men

1550/5117

30.3

Refa

Symptoms other than pain assessed during the last week of life

 Age

  41–64

22/87

25.3

1.572

0.966–2.560

0.069

  65–84

890/4830

18.4

1.049

0.960–1.146

0.294

  85–110

1940/10,692

18.1

Refa

 Gender

  Women

1984/10,584

18.7

1.080

0.988–1.181

0.091

  Men

868/5025

17.3

Refa

Oral health assessed during the last week of life

 Age

  41–64

78/93

83.9

1.712

0.983–2.981

0.058

  65–84

3696/4730

78.1

1.162

1.069–1.263

< 0.001

  85–110

7848/10,359

75.8

Refa

 Gender

  Women

7923/10,286

77.0

1.112

1.025–1.206

0.010

  Men

3699/4896

75.6

Refa

Next of kin informed about transition to end-of-life care

 Age

  41–64

72/90

80.0

1.630

0.970–2.739

0.065

  65–84

3549/4733

75.0

1.224

1.131–1.325

< 0.001

  85–110

7308/10,355

70.6

Refa

 Gender

  Women

7331/10,274

71.4

0.959

0.887–1.036

0.289

  Men

3598/4904

73.4

Refa

Next of kin offered a follow-up talk after death of the patient

 Age

  41–64

69/84

82.1

1.776

1.005–3.140

0.048

  65–84

3119/4152

75.1

1.161

1.064–1.265

0.001

  85–110

6772/9258

73.1

Refa

 Gender

  Women

6828/9217

74.1

0.983

0.903–1.071

0.701

  Men

3132/4277

73.2

Refa

Documented decision to shift to end-of-life care

 Age

  41–64

75/84

89.3

1.066

0.531–2.141

0.858

  65–84

4145/4574

90.6

1.216

1.079–1.371

0.001

  85–110

8971/10,050

89.3

Refa

 Gender

  Women

8934/9924

90.0

1.083

0.966–1.215

0.171

  Men

4257/4784

89.0

Refa

Specialised palliative care team consulted

 Age

  41–64

3/95

3.2

2.895

0.902–9.293

0.074

  65–84

84/5112

1.6

1.461

1.103–1.937

0.008

  85–110

127/11,255

1.1

Refa

 Gender

  Women

147/11,120

1.3

1.181

0.877–1.590

0.274

  Men

67/5342

1.3

Refa

Someone present at the moment of death

 Age

  41–64

85/93

91.4

1.505

0.720–3.147

0.277

  65–84

4554/5043

90.3

1.340

1.197–1.501

< 0.001

  85–110

9724/11,035

88.1

Refa

 Gender

  Women

9691/10,915

88.8

0.904

0.811–1.008

0.070

  Men

4672/5256

88.9

Refa

Pressure ulcers at death

 Age

  41–64

13/94

13.8

0.829

0.460–1.496

0.534

  65–84

767/5055

15.2

0.943

0.859–1.036

0.221

  85–110

1717/11,156

15.4

Refa

 Gender

  Women

1613/11,031

14.6

0.876

0.799–0.960

0.005

  Men

884/5274

16.8

Refa

  1. a Reference